[(1S,2R,5S)-6-BENZYL-8-METHYL-7,9-DIOXO-6,8-DIAZABICYCLO-[3.2.2]-NONAN-2-YL]-(2R)-3,3,3-TRIFLUORO-2-METHOXY-2-PHENYLPROPANOATE
Compound with spectra: 1 NMR
![[(1S,2R,5S)-6-BENZYL-8-METHYL-7,9-DIOXO-6,8-DIAZABICYCLO-[3.2.2]-NONAN-2-YL]-(2R)-3,3,3-TRIFLUORO-2-METHOXY-2-PHENYLPROPANOATE](/api/compound/7s6Krnts4IH.png?ph=true&h=300&w=458 "[(1S,2R,5S)-6-BENZYL-8-METHYL-7,9-DIOXO-6,8-DIAZABICYCLO-[3.2.2]-NONAN-2-YL]-(2R)-3,3,3-TRIFLUORO-2-METHOXY-2-PHENYLPROPANOATE")
| SpectraBase Compound ID | 7s6Krnts4IH |
|---|---|
| InChI | InChI=1S/C25H25F3N2O5/c1-29-20-19(35-23(33)24(34-2,25(26,27)28)17-11-7-4-8-12-17)14-13-18(21(29)31)30(22(20)32)15-16-9-5-3-6-10-16/h3-12,18-20H,13-15H2,1-2H3/t18-,19+,20+,24+/m0/s1 |
| InChIKey | VCQORACKWVYEDI-UECWXEIQSA-N |
| Mol Weight | 490.48 g/mol |
| Molecular Formula | C25H25F3N2O5 |
| Exact Mass | 490.171556 g/mol |
| Enantiomer InChIKey | VCQORACKWVYEDI-XUJKJYMVSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
(+)-(1S,2R,5S)-6-Allyl-8-(2,4-dimethoxybenzyl)-2-phenoxy-6,8-diazabicyclo[3.2.2]nonane-7,9-dione
(+)-(1S,2S,5S)-6-Allyl-8-(2,4-dimethoxybenzyl)-2-phenoxy-6,8-diazabicyclo[3.2.2]nonane-7,9-dione
Moexipril-M/artifact -H2O TMS @
(+)-(1S,2S,5S)-6-Allyl-2-benzyloxy-8-(2,4-dimethoxybenzyl)-6,8-diazabicyclo[3.2.2]nonane-7,9-dione
(+)-(1S,2R,5S)-6-Allyl-2-benzyloxy-8-(2,4-dimethoxybenzyl)-6,8-diazabicyclo[3.2.2]nonane-7,9-dione
FQIRXCYGRQNHHQ-HSAUHJMWSA-N
ICHTHYOPEPTIN_A
H-GLU-TYR-[SO2C6H4[4-(CO-A)]]-LEU-OBZL
Radarin D
| Title | Journal or Book | Year |
|---|---|---|
| Conformationally constrained ethylenediamines: synthesis and receptor binding of 6,8-Diazabicyclo[3.2.2]nonanes | Bioorganic & Medicinal Chemistry | 2002 |